Clinical Outcome of Eradication Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to H. pylori Infection Status
Background. To evaluate the long-term outcome of H. pylori eradication therapy for gastric MALT lymphoma according to the presence of H. pylori infection. Methods. We retrospectively reviewed the medical records of patients between January 2001 and June 2014. The clinicopathologic characteristics an...
Main Authors: | Ju Seok Kim, Sun Hyung Kang, Hee Seok Moon, Jae Kyu Sung, Hyun Yong Jeong |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/6794848 |
Similar Items
-
Clinical Efficacy of Radiotherapy in Helicobacter pylori Negative or Unresponsive to Eradication Therapy Primary Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
by: Byung Sam Park, et al.
Published: (2019-01-01) -
Helicobacter pylori-negative Gastric Mucosa-associated Lymphoid Tissue Lymphoma
by: Jin Tae Jung
Published: (2017-09-01) -
Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta analysis
by: Ya-Lin Xie, et al.
Published: (2020-06-01) -
Correction: Overexpression of and in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Resistant to Eradication.
by: Yoshimasa Saito, et al.
Published: (2013-01-01) -
Mucosa-Associated Lymphoid Tissue Lymphoma of the Lacrimal Gland: Sustained Remission after Eradication of Helicobacter Pylori Infection
by: Mohammed Hasosah, et al.
Published: (2011-01-01)